These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35026764)

  • 1. Potentials of CCL21 and CBS as Therapeutic Approaches for Breast Cancer.
    Peng J; Zhang D
    Eur Surg Res; 2022; 63(4):211-223. PubMed ID: 35026764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of cystathionine beta-synthase and chemokine ligand 21 is closely associated with poor prognosis in extrahepatic cholangiocarcinoma.
    Wang L; Yang Z; Wu Z; He J; Xu S; Li D; Zou Q; Yuan Y
    Medicine (Baltimore); 2020 Sep; 99(38):e22255. PubMed ID: 32957374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Significance of CBS and CCL21 in Gallbladder Adenocarcinomas and Squamous Cell/Adenosquamous Carcinomas.
    Li D; Yang Z; Liu Z; Zou Q; Yuan Y
    Appl Immunohistochem Mol Morphol; 2020 Feb; 28(2):103-110. PubMed ID: 32044878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of LINC00665 inhibits proliferation and invasion of breast cancer via competitive binding of miR-3619-5p and inhibition of catenin beta 1.
    Lv M; Mao Q; Li J; Qiao J; Chen X; Luo S
    Cell Mol Biol Lett; 2020; 25():43. PubMed ID: 32983239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7.
    Kim SJ; Shin JY; Lee KD; Bae YK; Sung KW; Nam SJ; Chun KH
    Breast Cancer Res; 2012 Jan; 14(1):R14. PubMed ID: 22251626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-566 protects the malignant progression of breast cancer by negatively regulating WNT6.
    Zhao MC; Zhang MM; Li T; Tao ZH; Du YQ; Wang LP; Zhang J; Wang BY; Hu XC
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6185-6194. PubMed ID: 32572884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells.
    Takeuchi H; Fujimoto A; Tanaka M; Yamano T; Hsueh E; Hoon DS
    Clin Cancer Res; 2004 Apr; 10(7):2351-8. PubMed ID: 15073111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexpression of EphA10 and Gli3 promotes breast cancer cell proliferation, invasion and migration.
    Peng J; Zhang D
    J Investig Med; 2021 Aug; 69(6):1215-1221. PubMed ID: 33990369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-216a-5p act as a tumor suppressor, regulating the cell proliferation and metastasis by targeting PAK2 in breast cancer.
    Zhang Y; Lin P; Zou JY; Zou G; Wang WZ; Liu YL; Zhao HW; Fang AP
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2469-2475. PubMed ID: 30964173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment.
    Yang SS; Ma S; Dou H; Liu F; Zhang SY; Jiang C; Xiao M; Huang YX
    Exp Cell Res; 2020 Jun; 391(2):111983. PubMed ID: 32268136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis.
    Tutunea-Fatan E; Majumder M; Xin X; Lala PK
    Mol Cancer; 2015 Feb; 14():35. PubMed ID: 25744065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA SNHG7 promotes development of breast cancer by regulating microRNA-186.
    Luo X; Song Y; Tang L; Sun DH; Ji DG
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7788-7797. PubMed ID: 30536320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusion of CCL21 non-migratory active breast epithelial and breast cancer cells give rise to CCL21 migratory active tumor hybrid cell lines.
    Berndt B; Haverkampf S; Reith G; Keil S; Niggemann B; Zänker KS; Dittmar T
    PLoS One; 2013; 8(5):e63711. PubMed ID: 23667660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics identification of CCL8/21 as potential prognostic biomarkers in breast cancer microenvironment.
    Chen B; Zhang S; Li Q; Wu S; He H; Huang J
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33146700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway.
    Zhang L; Wang D; Li Y; Liu Y; Xie X; Wu Y; Zhou Y; Ren J; Zhang J; Zhu H; Su Z
    PLoS One; 2016; 11(8):e0158529. PubMed ID: 27505247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCL21/CCR7 axis activating chemotaxis accompanied with epithelial-mesenchymal transition in human breast carcinoma.
    Li F; Zou Z; Suo N; Zhang Z; Wan F; Zhong G; Qu Y; Ntaka KS; Tian H
    Med Oncol; 2014 Sep; 31(9):180. PubMed ID: 25142946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and regulatory function of miRNA-182 in triple-negative breast cancer cells through its targeting of profilin 1.
    Liu H; Wang Y; Li X; Zhang YJ; Li J; Zheng YQ; Liu M; Song X; Li XR
    Tumour Biol; 2013 Jun; 34(3):1713-22. PubMed ID: 23430586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linc00707 promotes cell proliferation, invasion, and migration via the miR-30c/CTHRC1 regulatory loop in breast cancer.
    Yuan RX; Bao D; Zhang Y
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4863-4872. PubMed ID: 32432749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokine (C‑C motif) ligand 21/C‑C chemokine receptor type 7 triggers migration and invasion of human lung cancer cells by epithelial‑mesenchymal transition via the extracellular signal‑regulated kinase signaling pathway.
    Zhong G; Chen L; Yin R; Qu Y; Bao Y; Xiao Q; Zhang Z; Shen Y; Li C; Xu Y; Zou Z; Tian H
    Mol Med Rep; 2017 Jun; 15(6):4100-4108. PubMed ID: 28487957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.